咨询与建议

限定检索结果

文献类型

  • 2 篇 期刊文献

馆藏范围

  • 2 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 2 篇 医学
    • 2 篇 临床医学

主题

  • 2 篇 diagnostic indic...
  • 1 篇 sle^(x)
  • 1 篇 invasive micropa...
  • 1 篇 drug resistance
  • 1 篇 pancreatic ducta...
  • 1 篇 ema
  • 1 篇 polarity reversa...
  • 1 篇 therapeutic targ...
  • 1 篇 long non-coding ...
  • 1 篇 molecular mechan...

机构

  • 1 篇 the national and...
  • 1 篇 school of pharma...

作者

  • 1 篇 chijuan wang
  • 1 篇 yongjie ma
  • 1 篇 feng gu
  • 1 篇 xiaojiao chen
  • 1 篇 yi-ping mou
  • 1 篇 xue-ni sun
  • 1 篇 fangfang liu
  • 1 篇 weidong li
  • 1 篇 jianke lyu
  • 1 篇 xin-bing sui
  • 1 篇 kailiang wu
  • 1 篇 li fu
  • 1 篇 jiao feng
  • 1 篇 ting duan
  • 1 篇 xiao-yin jiang
  • 1 篇 qi-cong zhu
  • 1 篇 jing xu
  • 1 篇 jingyue zhang
  • 1 篇 xiao-jian zhang
  • 1 篇 yawen song

语言

  • 2 篇 英文
检索条件"主题词=diagnostic indicator"
2 条 记 录,以下是1-10 订阅
排序:
sLe^(x) expression in invasive micropapillary breast carcinoma is associated with poor prognosis and can be combined with MUC1/EMA as a supplementary diagnostic indicator
收藏 引用
Cancer Biology & Medicine 2021年 第2期18卷 477-489页
作者: Yawen Song Hui Sun Kailiang Wu Jianke Lyu Jingyue Zhang Feng Gu Yongjie Ma Beibei Shen Chijuan Wang Xiaojiao Chen Jing Xu Weidong Li Fangfang Liu Li Fu Department of Breast Cancer Pathology and Research Laboratory Tianjin Medical University Cancer Institute and HospitalNational Clinical Research Center for CancerKey Laboratory of Cancer Prevention and TherapyTianjinTianjin’s Clinical Research Center for CancerKey Laboratory of Breast Cancer Prevention and TherapyTianjin Medical UniversityMinistry of EducationBreast Cancer Innovation Team of the Ministry of EducationState Key Laboratory of Breast Cancer ResearchTianjin 300060China
Objective: Mucin 1(MUC1/EMA) and sialyl Lewis X(sLe^(x)) indicate polarity reversal in invasive micropapillary carcinoma(IMPC). The purpose of this study was to evaluate the expression of MUC1/EMA and sLe^(x) and to a... 详细信息
来源: 维普期刊数据库 维普期刊数据库 同方期刊数据库 同方期刊数据库 评论
Roles of lncRNAs in pancreatic ductal adenocarcinoma: Diagnosis,treatment, and the development of drug resistance
收藏 引用
Hepatobiliary & Pancreatic Diseases International 2023年 第2期22卷 128-139页
作者: Xiao-Yin Jiang Qi-Cong Zhu Xiao-Jian Zhang Ting Duan Jiao Feng Xin-Bing Sui Xue-Ni Sun Yi-Ping Mou The National and Local Joint Engineering Research Center for Biomanufacturing of Chiral Chemicals Zhejiang University of TechnologyHangzhou 310014China Department of Gastrointestinal and Pancreatic Surgery Key Laboratory of Gastroenterology of Zhejiang ProvinceZhejiang Provincial People’s HospitalAffiliated People’s Hospital of Hangzhou Medical CollegeHangzhou 310014China School of Pharmacy Hangzhou Normal UniversityHangzhou 311121China
Background: Pancreatic ductal adenocarcinoma(PDAC) is one of the most lethal cancers, primarily due to its late diagnosis, high propensity to metastasis, and the development of resistance to chemo-/radiotherapy. Accum... 详细信息
来源: 维普期刊数据库 维普期刊数据库 同方期刊数据库 同方期刊数据库 评论